The current national monitoring of routine wellness care and vaccine uptake does not provide data on health maintenance among pediatric populations with chronic medical conditions. In this case-control study that analyzes wellness visits and vaccine uptake among adolescents, ages 16 to 18 years, we identified 938 without (controls) and 74 with (cases) 1 of 12 specific chronic medical conditions. The PPSV23 (23-valent pneumococcal polysaccharide vaccine) is recommended by the Advisory Committee on Immunization Practices for these 12 conditions and served as a measure of uptake for medically indicated vaccines. Our controls were twice as likely as cases to have a documented well visit in the past year, and there was a significantly higher proportion of controls than cases vaccinated with Tdap (tetanus toxoid, reduced diphtheria toxoid, acellular pertussis), MCV-4 (quadrivalent meningococcal conjugate), and HPV (human papillomavirus), all P < .05. More than 60% of cases failed to receive PPSV23. Adolescents with chronic medical conditions are at high risk of neglecting routine health maintenance.
HarrisJGMalettaKIRenBOlsonJC.Improving pneumococcal vaccination in pediatric rheumatology patients. Pediatrics. 2015;136:e681-e686.
4.
GiannattasioASquegliaVLo VecchioA. Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Ital J Pediatr. 2010;36:28.
5.
DaviesPNwokoroCLeighM.Vaccinations against influenza and pneumococcus in children with diabetes: telephone questionnaire survey. BMJ. 2004;328:203.
6.
CugleyKCrawfordNRoyleJEliaSMassieJ.Immunisation rates of children with cystic fibrosis using the Australian Childhood Immunisation Register. J Paediatr Child Health. 2010;46:768-771.
7.
MooreAHarrisRSelvaduraiD.Optimizing pneumococcal vaccination for paediatric cochlear implant recipients using the cochlear implant pneumococcal vaccination flowchart. Cochlear Implants Int. 2012;13:193-196.
8.
NuortiJPWhitneyCG.Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-11):1-18.
9.
DunnACBlackCLArnoldJBrodineSWaalenJBinkinN.Childhood vaccination coverage rates among military dependents in the United States. Pediatrics. 2015;135:e1148-e1156.
10.
LopreiatoJOMoriartyR.Immunization status of a military dependent population. Mil Med. 1993;158:371-373.
11.
LopreiatoJOOttoliniMC.Assessment of immunization compliance among children in the Department of Defense health care system. Pediatrics. 1996;97:308-311.
12.
MorrowALRosenthalJLakkisHD. A population-based study of access to immunization among urban Virginia children served by public, private, and military health care systems. Pediatrics. 1998;101(2):E5.
13.
GeoffreyRSCynthiaBGrahamAB3rd. 2014 recommendations for pediatric preventive health care. Pediatrics. 2014;133:568-570.
14.
BlackLI.QuickStats: Percentage of youths aged 10-17 years who did not receive a well-child checkup in the past 12 months, by metropolitan status of residence—National Health Interview Survey, United States, 2008-2014. MMWR Morb Mortal Wkly Rep. 2016;64(52):1410.
15.
LuPJYankeyDJeyarajahJ. HPV vaccination coverage of male adolescents in the United States. Pediatrics. 2015;136:839-849.
16.
EpsteinD.High immunization rates versus missed immunization opportunities in a private pediatric office. Del Med J. 1998;70:361-366.
17.
BanaszkiewiczAKlincewiczBŁazowska-PrzeorekI. Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respir Viruses. 2014;8:431-435.
18.
Centers for Disease Control and Prevention. Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions—United States, 2011-12 influenza season. MMWR Morb Mortal Wkly Rep. 2013;62(36):744-746.
19.
GreenwoodVJCrawfordNWWalstabJEReddihoughDS.Immunisation coverage in children with cerebral palsy compared with the general population. J Paediatr Child Health. 2013;49:E137-E141.
20.
NakamuraMMLeeGM.Influenza vaccination in adolescents with high-risk conditions. Pediatrics. 2008;122:920-928.
21.
PandolfiECarloniEMarinoMG. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine. 2012;30:5172-5178.
22.
RabboneIScaramuzzaAEIafuscoD. Pandemic influenza vaccination coverage in children with type 1 diabetes: analysis from seven Italian centers. Hum Vaccin. 2011;7:1291-1292.
23.
SobotaAEKavanaghPLAdamsWGMcClureEFarrellDSprinzPG.Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic. Pediatr Blood Cancer. 2015;62:654-657.
24.
Weil-OlivierCAngoulvantFChevallierB. Influenza vaccination coverage rate in children with underlying chronic disorders in 7 French pediatric wards [in French]. Arch Pediatr. 2006;13:1287-1293.
25.
MassonALaunayODelaisiB. Vaccine coverage in CF children: a French multicenter study. J Cyst Fibros. 2015;14:615-620.
26.
Murris-EspinMAubertMBosdureEDubusJC.Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006. Vaccine. 2008;26:5612-5618.
27.
MogayzelPJJrNaureckasETRobinsonKA. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680-689.
